WFRD:NASDAQWeatherford International plc Analysis
Data as of 2026-08-26 - not real-time
$88.20
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
At $88.20, Weatherford International plc shows no decisive moving-average alignment, leaving the trend neutral. The last 30 days have gained 7.5%. Relative strength is 46.9 — neutral — and the MACD signal is bearish. Price has been bracketed by support at $82.17 and resistance at $95.71.
The shares look undervalued, trading on 17.4 times earnings below a sector average of 20.9. Sell-side targets cluster 32.6% above the current quote. Revenue is contracting at 8.2% on a 7.7% profit margin. The 1.25% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 6 — elevated. With 30-day volatility of 43.1%, a beta of 1.14 and a maximum drawdown of 29.8%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.
The shares look undervalued, trading on 17.4 times earnings below a sector average of 20.9. Sell-side targets cluster 32.6% above the current quote. Revenue is contracting at 8.2% on a 7.7% profit margin. The 1.25% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 6 — elevated. With 30-day volatility of 43.1%, a beta of 1.14 and a maximum drawdown of 29.8%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.
Top Market Events
Weatherford International plc has reported past second-quarter 2026 results, with revenue of US$1,105 million and net...Weatherford International PLC WFRD reports robust Q2 2026 results with significant revenue and EBITDA growth, while...Weatherford's Middle East operations cratered on Iran conflict turmoil, sending earnings down 39% below consensus to $0.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading below the 200-day average of 91.47
- MACD momentum is negative
- 30-day price change of +7.5%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 17.4 versus sector average of 20.9
- Trading below the 200-day average of 91.47
- Analyst targets imply +32.6% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 17.4 versus sector average of 20.9
- Analyst targets imply +32.6% versus the current price
- Revenue contracting at -8.2%
Key Metrics & Analysis
Financial Health
Revenue Growth-8.20%
Profit Margin7.66%
P/E Ratio17.4
ROE22.79%
ROA7.90%
Debt/Equity90.67
P/B Ratio3.5
Op. Cash Flow$717.0M
Free Cash Flow$558.0M
Industry P/E20.9
Technical Analysis
TrendNeutral
RSI46.9
Support$82.17
Resistance$95.71
MA 20$89.94
MA 50$87.17
MA 200$91.47
MACDBearish
VolumeDecreasing
Fear & Greed Index93.45
Valuation
Fair Value$92.21
Target Price$116.92
Upside/Downside32.56%
GradeUndervalued
TypeBlend
Dividend Yield1.25%
Risk Assessment
Beta1.14
Volatility43.14%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.